Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis

20051,939 citationsJournal Article

Authors

Jeanet W. Blom · Leiden University Medical Center

Abstract

Patients with cancer have a highly increased risk of venous thrombosis especially in the first few months after diagnosis and in the presence of distant metastases. Carriers of the factor V Leiden and prothrombin 20210A mutations appear to have an even higher risk.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Blood Coagulation and Thrombosis Mechanisms Cardiac tumors and thrombi

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 293, Issue 6, pp. 715-715

DOI: 10.1001/jama.293.6.715

Field-Weighted Citation Impact: 42.73